Derek L Isenberg1, Kevin A Henry2, Adam Sigal3, Traci Deaner3, Jason T Nomura4, Kathleen A Murphy4, Derek Cooney5, Susan Wojcik5, Ethan S Brandler6, Alexander Kuc7, Gerard Carroll7, Chadd K Kraus8, Judy B Shahan8, Joseph Herres9, Daniel Ackerman10, Nina T Gentile11. 1. Department of Emergency Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA. Derek.isenberg@tuhs.temple.edu. 2. Department Geography and Urban Studies, Temple University, Philadelphia, PA, USA. 3. Department of Emergency Medicine, Tower Health, Reading, PA, USA. 4. Department of Emergency Medicine, ChristianaCare, Newark, DE, USA. 5. Department of Emergency Medicine, State University of New York-Upstate Campus, Syracuse, NY, USA. 6. Deparement of Emergency Medicine, Stony Brook Medicine, Stony Brook, NY, USA. 7. Department of Emergency Medicine, Cooper Medical School of Rowan University, Camden, NJ, USA. 8. Department of Emergency Medicine, Geisinger, Danville, PA, USA. 9. Department of Emergency Medicine, Einstein Healthcare Network, Philadelphia, PA, USA. 10. Department of Neurology, St. Luke's University Health Network, Bethlehem, PA, USA. 11. Department of Emergency Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
Abstract
BACKGROUND: Large vessel occlusion (LVO) strokes are best treated with rapid endovascular therapy (EVT). There are two routes that LVO stroke patients can take to EVT therapy when transported by EMS: primary transport (ambulance transports directly to an endovascular stroke center (ESC) or secondary transport (EMS transports to a non-ESC then transfers for EVT). There is no clear evidence which path to care results in better functional outcomes for LVO stroke patients. To find this answer, an analysis of a large, real-world population of LVO stroke patients must be performed. METHODS: A pragmatic registry of LVO stroke patients from nine health systems across the United States. The nine health systems span urban and rural populations as well as the spectrum of socioeconomic statuses. We will use univariate and multivariate analysis to explore the relationships between type of EMS transport, socioeconomic factors, and LVO stroke outcomes. We will use geographic information systems and spatial analysis to examine the complex movements of patients in time and space. To detect an 8% difference between groups, with a 3:1 patient ratio of primary to secondary transports, 95% confidence and 80% power, we will need approximately 1600 patients. The primary outcome is the patients with modified Rankin Scale (mRS) ≤ 2 at 90 days. Subgroup analyses include patients who receive intravenous thrombolysis and duration of stroke systems. Secondary analyses include socioeconomic factors associated with poor outcomes after LVO stroke. DISCUSSION: Using the data obtained from the OPUS-REACH registry, we will develop evidence based algorithms for prehospital transport of LVO stroke patients. Unlike prior research, the OPUS-REACH registry contains patient-level data spanning from EMS dispatch to ninety day functional outcomes. We expect that we will find modifiable factors and socioeconomic disparities associated with poor outcomes in LVO stroke. OPUS-REACH with its breadth of locations, detailed patient records, and multidisciplinary researchers will design the optimal prehospital stroke system of care for LVO stroke patients.
BACKGROUND: Large vessel occlusion (LVO) strokes are best treated with rapid endovascular therapy (EVT). There are two routes that LVO stroke patients can take to EVT therapy when transported by EMS: primary transport (ambulance transports directly to an endovascular stroke center (ESC) or secondary transport (EMS transports to a non-ESC then transfers for EVT). There is no clear evidence which path to care results in better functional outcomes for LVO stroke patients. To find this answer, an analysis of a large, real-world population of LVO stroke patients must be performed. METHODS: A pragmatic registry of LVO stroke patients from nine health systems across the United States. The nine health systems span urban and rural populations as well as the spectrum of socioeconomic statuses. We will use univariate and multivariate analysis to explore the relationships between type of EMS transport, socioeconomic factors, and LVO stroke outcomes. We will use geographic information systems and spatial analysis to examine the complex movements of patients in time and space. To detect an 8% difference between groups, with a 3:1 patient ratio of primary to secondary transports, 95% confidence and 80% power, we will need approximately 1600 patients. The primary outcome is the patients with modified Rankin Scale (mRS) ≤ 2 at 90 days. Subgroup analyses include patients who receive intravenous thrombolysis and duration of stroke systems. Secondary analyses include socioeconomic factors associated with poor outcomes after LVO stroke. DISCUSSION: Using the data obtained from the OPUS-REACH registry, we will develop evidence based algorithms for prehospital transport of LVO stroke patients. Unlike prior research, the OPUS-REACH registry contains patient-level data spanning from EMS dispatch to ninety day functional outcomes. We expect that we will find modifiable factors and socioeconomic disparities associated with poor outcomes in LVO stroke. OPUS-REACH with its breadth of locations, detailed patient records, and multidisciplinary researchers will design the optimal prehospital stroke system of care for LVO stroke patients.
In the United States, approximately 800,000 people experience a stroke each year [1]. Stroke causes one in six deaths from cardiovascular disease and is a leading cause of disability in the United States [2, 3]. Large vessel occlusion (LVO) strokes account for 11-31% of acute ischemic strokes (AIS) [4]. For LVO strokes, endovascular treatment (EVT) results in better outcomes than intravenous thrombolysis (IVT) alone [4-9].A recent study found that LVO strokes patients were over 3.5 times more likely to undergo EVT if they presented at an endovascular capable stroke center (ESC) compared to a non-ESC [10]. In addition, for every 15 min delay in EVT up to 270 min, there is a 1% worsening of good functional outcomes [11]. Hospital costs and lengths of stay are increased when patients are transferred for EVT compared to patients directly transported to an ESC [12]. Patients who require transfer for EVT are less likely to be discharged home and ambulate independently than patients transported directly to an ESC [13].There are two routes that LVO stroke patients can take to EVT therapy when transported by EMS: 1) transport a suspected LVO stroke patient directly to an ESC (primary transport) or 2) transport a patient to a non-ESC then transfers the patient to an ESC for EVT (secondary transport) (Fig. 1). EMS could transport every suspected LVO stroke patients to an ESC. However, there are costs to the healthcare system if an ambulance bypasses a non-ESC for an ESC. In a rural area, a longer transport duration may take an ambulance out of service for a significant amount of time. If a strategy of primary transport is undertaken for all suspected LVO stroke patients, patients will be over-triaged to ESCs when they do not require advanced resources. One study estimated an approximately 6-19% over-triage rate to CSC for LVO stroke [14].
Fig. 1
Primary versus secondary stroke transport
Primary versus secondary stroke transportThere is scant evidence examining the relationship of primary and secondary transport to ESC to functional outcomes. Several authors have attempted to address the design of stroke systems of care through modeling. Two studies have suggested that suggested that EMS should bypass community hospitals if the ESC is within a 60-min transport time, while another study suggested that EMS bypass community hospitals if within 20 min of an ESC [15-17]. One patient level study found an 8% increase in good functional outcomes when patients were transported directly to an ESC compared to those patents transferred for EVT [15]. However, this study was conducted in the context of a clinical trial where stroke processes were optimized. In addition, bypass times were estimated based on driving distances and a fictional on-scene time.To develop an evidence based algorithm for the transport of LVO stroke patients, an analysis of factors associated with functional outcomes needs to be performed on a large, real world population of LVO stroke patients. The Optimizing Prehospital Stroke Systems of Care-Reacting to Changing Paradigms (OPUS-REACH) registry is designed to answer this question.
Methods and design
Design
The Optimizing Prehospital Stroke Systems of Care-Reacting to Changing Paradigms (OPUS-REACH) registry will include information from nine health systems across the Northeastern United States. The registry includes data from EMS dispatch to 90 day outcome.
Participating sites
The OPUS-REACH consortium consists of nine health systems with the shared goal of studying and optimizing prehospital systems of care for LVO stroke patients (Table 1). These nine health systems consist of 46 acute care hospitals including 10 ESCs and span systems span urban, suburban, and rural areas (Figs. 2 and 3). The nine health systems account for over 1.7 million ED visits, over 10,000 stroke admissions, and approximately 850 mechanical thrombectomies annually (Supplement 1). The lead hospital in the OPUS-REACH network, Temple University, is an innovator in using Geographical Information Systems (GIS) to assess systems of healthcare delivery.
Table 1
Summary of health system data from OPUS-REACH
Health System
Acute Care Hospitals
Emergency Department Volume
Stroke Admissions
EVT procedures for acute stroke
Temple University Health System
3
200,000
500
40
Einstein Healthcare Network
3
162,000
620
40
Cooper University Hospital
1
80,000
600
140
Tower Health System
7
221,755
725
55
Geisinger
12
300,000
2000
160
State University of New York-Stony Brook
3
124,610
1000
200
St. Luke’s University Health Network
12
390,000
1800
83
ChristianaCare
3
200,000
1500
150
State University of New York- Upstate Campus
2
111,000
1900
90
Totals
46
1,789,445
10,645
858
Fig. 2
Map of endovascular stroke centers participating in OPUS-REACH
Fig. 3
Map of all acute care hospitals participating in OPUS-REACH
Summary of health system data from OPUS-REACHMap of endovascular stroke centers participating in OPUS-REACHMap of all acute care hospitals participating in OPUS-REACH
Patient population and eligibility
Our LVO stroke registry will include all patients from the nine health systems who have undergone EVT for LVO stroke between 2015 and 2020. Patients will be excluded if they were not transported to either the ESC or non-ESC by EMS or the patient does not have a 90 day functional outcome assessed.
Study procedures
Each spoke in the OPUS-REACH consortium has a site investigator (SI) responsible for oversight of data collection. These SI are primarily emergency physicians, but also include neurologists. Data collection for the OPUS-REACH registry will be extracted at each site individually and then submitted to a central registry housed at Temple University [18]. The REDCAP database is approved for the storage of protected health information. Only study personnel approved by the Institutional Review Board and designated by the principal investigator (DI) will have access to protected health information. All investigators listed on this manuscript will have access to de-identified data for the purpose of writing manuscripts for publication. Authorship will be determined based on the contributions of each investigator to the manuscript. Data and results will be disseminated via peer-reviewed journals in the fields of neurology, emergency medicine, and public health.
Outcomes
The main outcome variable is functional status at 90 days as measured by the Modified Rankin Scale (mRS) [19-22]. Scores of 0 to 2 are considered good outcomes while scores of 3 to 6 are considered poor outcomes. In the cases where a 90-day mRS may not be available, the SI from each site will review the electronic medical record for clinic notes, emergency department visits, or physical therapy notes, that would describe the patient’s functional outcome at 90 days. They will then assign a score of “good” or “poor functional outcome.” This approach has been documented as an accurate way to estimate a patient’s functional outcome [22].We will compare outcomes between patients transferred for EVT to those directly transported by EMS to an EVT center. We will stratify patients by eligibility for IVT as well as onset of stroke. We will also stratify patients by drive times, based on modeling, to the EVT center.
Data capture
Hospitals will identify LVO stroke patients treated with EVT at their facilities. For each patient who underwent an EVT, the SI will complete a standardized case report form (CRF). This CRF will include prehospital data, in-hospital data, and 90 day functional outcomes.
Sample size
A prior study showed an 8% absolute difference in outcomes for LVO stroke patients between patients who were transported directly to an ESC versus those who were transferred from a primary stroke center: 40% in the direct transport group v. 32% in the transfer group [21]. Therefore, to detect an 8% difference between groups, with a 3:1 patient ratio of primary to secondary transports, 95% confidence and 80% power, we will need approximately 1600 patients.
Statistical and spatial analysis
The use of GIS and spatial analysis moves prehospital system design from expert opinion to a data-driven process. Geocoding patient data (e.g., pick up locations), integrating it into a GIS, and linking it with other clinical data will provide the necessary platform to examine the complex movements of patients in time and space. We will map the paths to care for LVOs stroke patients and calculate times based on time of day, day of week, and traffic patterns.To examine geographic disparities in stroke care there are two methods we will apply. First, we will use spatial scan statistics. These methods generate circles (or ellipses) of various sizes and evaluate observed versus expected rate ratios (risk within circle compared to risk outside) to identify statistically significant “clusters” of outcomes including clustering over time. We will use this approach to find places in the study area where patients are statistically significantly more likely to not get transported directly to an ESC. Spatial scan statics will be estimated using the free software SaTScan. The second method we will use is a structured additive regression model based on a fully Bayesian approach via Markov Chain Monte Carlo (MCMC) simulations. These models can account for spatial and temporal random effects, spatial effects, and spatial-temporal interactions. These models provide geographically smoothed spatial parameter estimates that can be used to visualize disparities in stroke outcomes (e.g., places with a higher odd of not getting transported directly to an ESC) and provide specific location where outcomes are statistically significantly higher or lower (e.g., credible intervals in Bayesian methods) than the study areas average values.When comparing the outcomes of LVO stroke patients who underwent primary versus secondary outcomes, we will use univariate analysis of the both the primary group and the subgroups. Groups will be compared by X2 tests We will then perform multivariate analysis to control for individual stroke centers and initial NIHSS to verify our results. In addition, we will perform a regression analysis to determine the relationship of time to EVT to functional outcomes.To look at the effect of socioeconomic factors on LVO stroke outcomes, we will use the United States Centers for Disease Control and Prevention (CDC) Social Vulnerability Index (SVI) [23, 24] (Fig. 4). SVI components include socioeconomic status, minority status, and percentage of population over 65 years of age. Because the SVI is available at the level of the census tract, we will plot the SVI components against drive time to ESCs and determine the differences between populations and their access to care.
Fig. 4
US CDC Social Vulnerability Index
US CDC Social Vulnerability Index
Organization, funding, and registration
OPUS-REACH is support by a grant from the American Heart Association. Temple University will serve as the lead site and the other eight health systems will function as spokes of Temple University. The design of the registry as well as the study protocols were developed by the site investigators at all nine health systems. The study was approved by the Institutional Review Boards (IRB) at each health system. Any alternations in the study protocol will be submitted to each individual IRB for review. As this is a registry study, no trial registration is required.
Discussion
Using the data obtained from the OPUS-REACH registry, we will develop evidenced based algorithms for prehospital transport of LVO stroke patients. We expect that we will find modifiable factors that are associated with poor outcomes in LVO stroke. For example, we hypothesize that outcomes will be worse for patients who were secondarily transferred for EVT rather than directly transported to an ESC. If this is true, then delays may be related to the door-in-door-out time (DIDO) time at the transferring non-ESC (Fig. 5). Long DIDO times be associated with the level of stroke certification for a hospital, whether a hospital is part of an integrated health systems, or the processes for treating and transferring LVO stroke patients. On the other hand, delays in arriving at EVT capable hospitals may not be related to internal stroke processes at referring hospitals but to long transfer times to the ESC. In this case, a prehospital transport algorithm for a suspected LVO stroke patient would include greater emphasis on rapid direct transport including aeromedical transport.
Fig. 5
Primary and Secondary Time Intervals
Primary and Secondary Time Intervals
Conclusion
The OPUS-REACH registry will provide evidence for the creation of a prehospital stroke system of care for LVO patients. Unlike prior published research, we have data spanning from EMS dispatch to ninety day functional outcomes. The OPUS-REACH registry with its breadth of locations, detailed patient records, and multidisciplinary researchers from the fields of emergency medicine, medical geography, and neurology, is poised to design the optimal prehospital systems of care for LVO stroke patients.Additional file 1: Supplemental file 1. Description of the nine health systems in the OPUS-REACH consortium.
Authors: Gregory W Albers; Michael P Marks; Stephanie Kemp; Soren Christensen; Jenny P Tsai; Santiago Ortega-Gutierrez; Ryan A McTaggart; Michel T Torbey; May Kim-Tenser; Thabele Leslie-Mazwi; Amrou Sarraj; Scott E Kasner; Sameer A Ansari; Sharon D Yeatts; Scott Hamilton; Michael Mlynash; Jeremy J Heit; Greg Zaharchuk; Sun Kim; Janice Carrozzella; Yuko Y Palesch; Andrew M Demchuk; Roland Bammer; Philip W Lavori; Joseph P Broderick; Maarten G Lansberg Journal: N Engl J Med Date: 2018-01-24 Impact factor: 91.245
Authors: Salim S Virani; Alvaro Alonso; Emelia J Benjamin; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Alexander R Chang; Susan Cheng; Francesca N Delling; Luc Djousse; Mitchell S V Elkind; Jane F Ferguson; Myriam Fornage; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Tak W Kwan; Daniel T Lackland; Tené T Lewis; Judith H Lichtman; Chris T Longenecker; Matthew Shane Loop; Pamela L Lutsey; Seth S Martin; Kunihiro Matsushita; Andrew E Moran; Michael E Mussolino; Amanda Marma Perak; Wayne D Rosamond; Gregory A Roth; Uchechukwu K A Sampson; Gary M Satou; Emily B Schroeder; Svati H Shah; Christina M Shay; Nicole L Spartano; Andrew Stokes; David L Tirschwell; Lisa B VanWagner; Connie W Tsao Journal: Circulation Date: 2020-01-29 Impact factor: 29.690
Authors: Tudor G Jovin; Angel Chamorro; Erik Cobo; María A de Miquel; Carlos A Molina; Alex Rovira; Luis San Román; Joaquín Serena; Sonia Abilleira; Marc Ribó; Mònica Millán; Xabier Urra; Pere Cardona; Elena López-Cancio; Alejandro Tomasello; Carlos Castaño; Jordi Blasco; Lucía Aja; Laura Dorado; Helena Quesada; Marta Rubiera; María Hernandez-Pérez; Mayank Goyal; Andrew M Demchuk; Rüdiger von Kummer; Miquel Gallofré; Antoni Dávalos Journal: N Engl J Med Date: 2015-04-17 Impact factor: 91.245
Authors: Reza Jahan; Jeffrey L Saver; Lee H Schwamm; Gregg C Fonarow; Li Liang; Roland A Matsouaka; Ying Xian; DaJuanicia N Holmes; Eric D Peterson; Dileep Yavagal; Eric E Smith Journal: JAMA Date: 2019-07-16 Impact factor: 56.272
Authors: Bruce C V Campbell; Peter J Mitchell; Timothy J Kleinig; Helen M Dewey; Leonid Churilov; Nawaf Yassi; Bernard Yan; Richard J Dowling; Mark W Parsons; Thomas J Oxley; Teddy Y Wu; Mark Brooks; Marion A Simpson; Ferdinand Miteff; Christopher R Levi; Martin Krause; Timothy J Harrington; Kenneth C Faulder; Brendan S Steinfort; Miriam Priglinger; Timothy Ang; Rebecca Scroop; P Alan Barber; Ben McGuinness; Tissa Wijeratne; Thanh G Phan; Winston Chong; Ronil V Chandra; Christopher F Bladin; Monica Badve; Henry Rice; Laetitia de Villiers; Henry Ma; Patricia M Desmond; Geoffrey A Donnan; Stephen M Davis Journal: N Engl J Med Date: 2015-02-11 Impact factor: 91.245
Authors: Olvert A Berkhemer; Puck S S Fransen; Debbie Beumer; Lucie A van den Berg; Hester F Lingsma; Albert J Yoo; Wouter J Schonewille; Jan Albert Vos; Paul J Nederkoorn; Marieke J H Wermer; Marianne A A van Walderveen; Julie Staals; Jeannette Hofmeijer; Jacques A van Oostayen; Geert J Lycklama à Nijeholt; Jelis Boiten; Patrick A Brouwer; Bart J Emmer; Sebastiaan F de Bruijn; Lukas C van Dijk; L Jaap Kappelle; Rob H Lo; Ewoud J van Dijk; Joost de Vries; Paul L M de Kort; Willem Jan J van Rooij; Jan S P van den Berg; Boudewijn A A M van Hasselt; Leo A M Aerden; René J Dallinga; Marieke C Visser; Joseph C J Bot; Patrick C Vroomen; Omid Eshghi; Tobien H C M L Schreuder; Roel J J Heijboer; Koos Keizer; Alexander V Tielbeek; Heleen M den Hertog; Dick G Gerrits; Renske M van den Berg-Vos; Giorgos B Karas; Ewout W Steyerberg; H Zwenneke Flach; Henk A Marquering; Marieke E S Sprengers; Sjoerd F M Jenniskens; Ludo F M Beenen; René van den Berg; Peter J Koudstaal; Wim H van Zwam; Yvo B W E M Roos; Aad van der Lugt; Robert J van Oostenbrugge; Charles B L M Majoie; Diederik W J Dippel Journal: N Engl J Med Date: 2014-12-17 Impact factor: 91.245
Authors: Mayank Goyal; Andrew M Demchuk; Bijoy K Menon; Muneer Eesa; Jeremy L Rempel; John Thornton; Daniel Roy; Tudor G Jovin; Robert A Willinsky; Biggya L Sapkota; Dar Dowlatshahi; Donald F Frei; Noreen R Kamal; Walter J Montanera; Alexandre Y Poppe; Karla J Ryckborst; Frank L Silver; Ashfaq Shuaib; Donatella Tampieri; David Williams; Oh Young Bang; Blaise W Baxter; Paul A Burns; Hana Choe; Ji-Hoe Heo; Christine A Holmstedt; Brian Jankowitz; Michael Kelly; Guillermo Linares; Jennifer L Mandzia; Jai Shankar; Sung-Il Sohn; Richard H Swartz; Philip A Barber; Shelagh B Coutts; Eric E Smith; William F Morrish; Alain Weill; Suresh Subramaniam; Alim P Mitha; John H Wong; Mark W Lowerison; Tolulope T Sajobi; Michael D Hill Journal: N Engl J Med Date: 2015-02-11 Impact factor: 91.245
Authors: Shreyansh Shah; Ying Xian; Shubin Sheng; Kori S Zachrison; Jeffrey L Saver; Kevin N Sheth; Gregg C Fonarow; Lee H Schwamm; Eric E Smith Journal: Circulation Date: 2019-03-26 Impact factor: 29.690
Authors: Derek L Isenberg; Kevin A Henry; Adam Sigal; Traci Deaner; Jason T Nomura; Kathleen A Murphy; Derek Cooney; Susan Wojcik; Ethan S Brandler; Alexander Kuc; Gerard Carroll; Chadd K Kraus; Judy B Shahan; Joseph Herres; Daniel Ackerman; Nina T Gentile Journal: BMC Neurol Date: 2022-05-07 Impact factor: 2.474